Speaker illustration

Professor Nick Finer

University College London, London (United Kingdom of Great Britain & Northern Ireland)

Nick is honorary clinical professor at the National Centre for Cardiovascular Prevention and Outcomes, UCL Institute of Cardiovascular Science; from 2016-2022 he was Senior Principal Clinical Scientist, Global Medical Affairs, with Novo Nordisk in Denmark. His research on obesity and its related complications is represented by 200 peer-reviewed papers and reviews, and more than 23 book chapters. Nick is past Chair of the UK Association for the Study of Obesity and World Obesity Federation Clinical Care, where amongst other roles he was responsible for developing the SCOPE educational programme; he has held positions with the UK Government Advisory Group on Obesity, NICE Public Health Advisory Group, European Association for the Study of Obesity, and the European Society of Hypertension. He received the Bisset Hawkins Medal, a triennial award 'for work in advancing sanitary science or in promoting public health'. Nick was the founding Editor-in-Chief of Clinical Obesity from 2011-2022.

Diabetes, overweight and obesity – Global pandemics.

Event: EuroPrevent 2019

Topic: Diabetes and the Heart

Session: Masterclass on Diabetes & CV Risk Part 1: The patient with diabetes

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb